RCT study for neuropsychological treatment of memory performance of patients with MCI and mild Alzheimer's disease: „Memory Improvement in MCI and AD (MIMA)“

RCT study for neuropsychological treatment of memory performance of patients with MCI and mild Alzheimer's disease: „Memory Improvement in MCI and AD (MIMA)“ - MIMA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00019070

Enrollment

Registered

2019-11-11

Start date

2019-11-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00 F06.7

Interventions

Group 1: The intervention group gets a therapy to train their memory. All patients learn word lists, based on the item-specific encoding paradigm which means they not only have to remember the words i

Eligibility

Sex/Gender

All

Age

65 Years to 90 Years

Inclusion criteria

Inclusion criteria: Mini Mental Status Scores between 21 and 30

Exclusion criteria

Exclusion criteria: Geriatric Depression Scale Scores higher 5 exclude people from the study.

Design outcomes

Primary

Measure	Time frame
The study is finished after at least 32 patients participated in the study. The primary outcome is defined by MMSE-Score and quality of life because they are widely accepted standard measures. The quality of life is measured with the SF-12 questionnaire.	—

Secondary

Measure	Time frame
Die Studie wird beendet, wenn mindestens 32 Patienten ihre Teilnahme erfolgreich abgeschlossen haben. The CERAD test battery and the digit span forward and backwards from the Wechsler-Memory Scale are used as secondary outcomes.	—

Countries

Germany

Contacts

Public ContactAlexa Karp

Carl von Ossietzky Universität OldenburgDepartment für Psychologie

alexa.karp@uni-oldenburg.de01783023263

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026